Acetylation inactivates the transcriptional repressor BCL6
- PMID: 12402037
- DOI: 10.1038/ng1018
Acetylation inactivates the transcriptional repressor BCL6
Abstract
The proto-oncogene BCL6 encodes a BTB/POZ-zinc finger transcriptional repressor that is necessary for germinal-center formation and has been implicated in the pathogenesis of B-cell lymphomas. Here we show that the co-activator p300 binds and acetylates BCL6 in vivo and inhibits its function. Acetylation disrupts the ability of BCL6 to recruit histone deacetylases (HDACs), thereby hindering its capacity to repress transcription and to induce cell transformation. BCL6 is acetylated under physiologic conditions in normal germinal-center B cells and in germinal center-derived B-cell tumors. Treatment with specific inhibitors shows that levels of acetylation of BCL6 are controlled by both HDAC-dependent and SIR2-dependent pathways. Pharmacological inhibition of these pathways leads to the accumulation of the inactive acetylated BCL6 and to cell-cycle arrest and apoptosis in B-cell lymphoma cells. These results identify a new mechanism of regulation of the proto-oncogene BCL6 with potential for therapeutic exploitation. Furthermore, these findings provide a new mechanism by which acetylation can promote transcription not only by modifying histones and activating transcriptional activators, but also by inhibiting transcriptional repressors.
Similar articles
-
The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells.Nature. 2004 Dec 2;432(7017):635-9. doi: 10.1038/nature03147. Nature. 2004. PMID: 15577913
-
BCL6 interacts with the transcription factor Miz-1 to suppress the cyclin-dependent kinase inhibitor p21 and cell cycle arrest in germinal center B cells.Nat Immunol. 2005 Oct;6(10):1054-60. doi: 10.1038/ni1245. Epub 2005 Sep 4. Nat Immunol. 2005. PMID: 16142238
-
The LAZ3/BCL6 oncogene encodes a sequence-specific transcriptional inhibitor: a novel function for the BTB/POZ domain as an autonomous repressing domain.Cell Growth Differ. 1995 Dec;6(12):1495-503. Cell Growth Differ. 1995. PMID: 9019154
-
Targeted somatic mutation of the BCL6 proto-oncogene and its impact on lymphomagenesis.Hematology. 2005 Apr;10(2):115-29. doi: 10.1080/10245330400026105. Hematology. 2005. PMID: 16019457 Review.
-
The proto-oncogene BCL-6 in normal and malignant B cell development.Hematol Oncol. 2002 Dec;20(4):155-66. doi: 10.1002/hon.689. Hematol Oncol. 2002. PMID: 12469325 Review.
Cited by
-
Key Functions of the Transcription Factor BCL6 During T-Cell Differentiation.Adv Exp Med Biol. 2024;1459:79-94. doi: 10.1007/978-3-031-62731-6_4. Adv Exp Med Biol. 2024. PMID: 39017840 Review.
-
The F-box E3 ligase protein FBXO11 regulates EBNA3C-associated degradation of BCL6.J Virol. 2024 Jul 23;98(7):e0054824. doi: 10.1128/jvi.00548-24. Epub 2024 Jun 12. J Virol. 2024. PMID: 38864622 Free PMC article.
-
DNMT1 driven by mouse amniotic fluid mesenchymal stem cell exosomes improved corneal cryoinjury via inducing microRNA-33 promoter DNA hypermethylation modification in corneal epithelium cells.Hum Cell. 2024 Jul;37(4):1091-1106. doi: 10.1007/s13577-024-01082-x. Epub 2024 May 23. Hum Cell. 2024. PMID: 38782857
-
Stochastic modeling of a gene regulatory network driving B cell development in germinal centers.PLoS One. 2024 Mar 28;19(3):e0301022. doi: 10.1371/journal.pone.0301022. eCollection 2024. PLoS One. 2024. PMID: 38547073 Free PMC article.
-
SIRT1 and HSP90α feed-forward circuit safeguards chromosome segregation integrity in diffuse large B cell lymphomas.Cell Death Dis. 2023 Oct 11;14(10):667. doi: 10.1038/s41419-023-06186-0. Cell Death Dis. 2023. PMID: 37816710 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous
